Mach 1: The Science Behind Maximum-Strength Sildenafil and Tadalafil for Erectile Dysfunction

Not every case of erectile dysfunction (ED) responds to standard first-line treatment. Research consistently shows that up to 30–40% of men do not achieve satisfactory results with a single PDE5 inhibitor at standard dosing — whether due to underlying vascular disease, diabetes, post-surgical nerve damage, or other complicating factors. For men in this category, the clinical question becomes: what comes next?

Mach 1 was built to answer that question. Combining Sildenafil 70mg with Tadalafil 20mg in a single on-demand formulation, it targets the two most clinically validated PDE5 inhibitors simultaneously — offering maximum-strength erectile support for men who need more than the baseline.

---

What Is Mach 1?

Mach 1 is an on-demand prescription treatment for erectile dysfunction. Each dose delivers:

• Sildenafil 70mg — a potent PDE5 inhibitor with rapid onset (30–60 minutes) and approximately 4–6 hours of active window
• Tadalafil 20mg — a long-acting PDE5 inhibitor with onset of 30–45 minutes and duration up to 36 hours

This isn't a higher dose of the same mechanism. Sildenafil and tadalafil differ in molecular structure, binding affinity profiles, half-life, and metabolic pathways — meaning they provide complementary, non-overlapping pharmacological activity. The result is a broader, more sustained erectile response than either compound delivers alone.

Like all OnyxMD treatments, Mach 1 is available by physician prescription only. You begin with a free online intake at questionnaire.getonyxmd.com.

---

The Case for Dual PDE5 Inhibition

PDE5 inhibitors work by blocking phosphodiesterase type 5, the enzyme that breaks down cyclic guanosine monophosphate (cGMP). When cGMP accumulates in smooth muscle cells of the corpus cavernosum, it triggers relaxation, vasodilation, and increased blood flow — the physiological substrate of an erection.

Different PDE5 inhibitors bind to the PDE5 enzyme with slightly different affinities and exhibit different selectivity profiles across the PDE isoenzyme family. Sildenafil and tadalafil both inhibit PDE5 but are structurally distinct molecules with different pharmacokinetic properties:

• Sildenafil has a plasma half-life of approximately 3–5 hours, providing sharp, time-limited action ideal for planned encounters
• Tadalafil has a half-life of approximately 17.5 hours, providing a prolonged window with more spontaneity

When combined under physician supervision, these differences translate to complementary coverage: rapid onset from the sildenafil component, sustained background support from tadalafil.

A 2021 systematic review and meta-analysis published in PMC evaluated combination PDE5 inhibitor approaches and concluded that combination therapy is safe, associated with improved outcomes, and should be considered as a first-line therapy for refractory, complex, or difficult-to-treat cases of ED (PMC7893498). The evidence increasingly supports multi-agent approaches in men where monotherapy is insufficient.

---

Who Is Mach 1 Designed For?

Mach 1 is a maximum-strength, on-demand formulation. It is not for every man with ED — it is specifically designed for those with moderate-to-severe or treatment-resistant dysfunction, including men who:

Have tried standard PDE5 inhibitors without adequate results Research indicates that up to 40% of men report an unsatisfactory response to first-line PDE5 inhibitor monotherapy (Cleveland Clinic Journal of Medicine, 2024). For these men, continuing to push single-agent doses often yields diminishing returns without a mechanistically different approach.

Have ED with a vascular or metabolic component Men with diabetes, hypertension, dyslipidemia, or metabolic syndrome often have more impaired endothelial function, requiring greater pharmacological support for adequate smooth muscle relaxation. Dual-agent therapy offers broader receptor engagement under challenging physiological conditions.

Prefer on-demand rather than daily dosing Unlike daily low-dose tadalafil regimens, Mach 1 is designed for situational use — taken when needed, rather than every day. The tadalafil component ensures the window extends well beyond a single encounter, reducing timing pressure.

Want the highest clinically-validated oral option For men who have weighed their options and want maximum pharmacological support under physician supervision, Mach 1 represents the top of the oral ED treatment hierarchy.

---

The Clinical Evidence Behind the Ingredients

Sildenafil: The Gold Standard, Enhanced

Sildenafil was the first oral PDE5 inhibitor approved for ED and remains among the most studied drugs in men's sexual health. The landmark 1998 clinical trials published in the New England Journal of Medicine demonstrated that sildenafil significantly improved erectile function and quadrupled the success of intercourse, with effectiveness maintained across at least six months of follow-up.

Subsequent clinical data reinforced this benchmark. A review of long-term real-world outcomes found that 75% successful intercourse was achieved by 82% of sildenafil patients, with 77% succeeding at every attempt in some cohorts (Guay et al., 2001, cited in PMC2699643). The drug's rapid onset — typically 30–60 minutes — makes it well-suited for on-demand use, while the 70mg dose in Mach 1 positions it between the standard 50mg and maximum 100mg prescriptions.

Tadalafil: The Long-Window Partner

Tadalafil's differentiated pharmacokinetics have made it a clinical standout since its approval. Its 17.5-hour half-life means a single dose taken before an encounter remains active well into the following day — a characteristic informally described as a "36-hour window" in clinical practice.

Studies comparing tadalafil's efficacy in men with difficult-to-treat ED have consistently demonstrated meaningful improvement in IIEF (International Index of Erectile Function) scores even in subgroups with underlying comorbidities. In the Mach 1 formulation, tadalafil provides the sustained baseline elevation of cGMP that complements sildenafil's sharper, faster peak.

Why the Combination Is Greater Than the Sum

The pharmacological rationale for combining sildenafil and tadalafil rests on three factors:

1. Structural diversity — different molecular scaffolds engage slightly different binding pockets and PDE isoform selectivity profiles
2. Kinetic complementarity — fast onset (sildenafil) + long duration (tadalafil) = comprehensive temporal coverage
3. Dose efficiency — achieving broad PDE5 inhibition through two compounds at moderate doses may carry a more favorable tolerability profile than escalating a single compound to maximum dose

This approach mirrors the combination pharmacology rationale used across other therapeutic areas — cardiovascular medicine, oncology, infectious disease — where targeting the same physiological pathway via two mechanistically distinct agents produces outcomes that neither can achieve alone.

---

How to Take Mach 1

Mach 1 is an on-demand treatment, taken approximately 30–60 minutes before sexual activity. The sildenafil component will begin providing support within this window; the tadalafil component extends the active period substantially beyond a single dose.

Key practical notes:

• Avoid high-fat meals immediately before dosing — sildenafil absorption is slowed by fat-rich food; tadalafil is less affected
• Alcohol in moderation — both compounds can cause mild blood pressure reduction; excessive alcohol may compound this
• Not for daily use — this formulation is designed for situational, on-demand dosing
• Never combine with nitrates — concurrent use of PDE5 inhibitors with nitrate medications (including recreational poppers) is contraindicated due to risk of severe hypotension
• Physician clearance is required — Mach 1 is prescription-only and requires a medical evaluation prior to dispensing

---

Frequently Asked Questions

Is combining sildenafil and tadalafil safe? Under physician supervision and with appropriate patient selection, combination PDE5 inhibitor therapy has a clinical track record. The PMC systematic review cited above found it to be safe with improved outcomes in appropriate candidates. Medical evaluation is mandatory — not a formality.

How does Mach 1 differ from simply taking Viagra at 100mg? Escalating sildenafil to 100mg increases the peak concentration of a single agent. Mach 1 instead adds a structurally distinct second compound (tadalafil) with different kinetics — rapid onset is maintained while the duration window extends dramatically. This is a different pharmacological strategy, not just a higher dose.

Can I switch to Mach 1 if another PDE5 inhibitor didn't work for me? This is a decision best made with a physician during your intake. If you have previously tried sildenafil or tadalafil at standard doses without adequate results, that history is relevant clinical information for the prescribing physician to assess.

---

Conclusion: When Standard Isn't Enough

For most men, first-line ED treatment works. But for those in the 30–40% for whom it doesn't — or who want the maximum clinically-supported option from the start — the pharmacological rationale for dual PDE5 inhibition is well-established in the literature.

Mach 1 exists for this segment: men who want maximum-strength, on-demand support under physician oversight, without escalating to invasive alternatives.

If you're ready to explore clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com.

You can also explore the full OnyxMD product range or browse additional men's health resources on the blog.

---

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.